Pembrolizumab for choroidal metastases from non-small cell lung cancer: a case report and literature review

Pembrolizumab for choroidal metastases from non-small cell lung cancer: a case report and literature review

We described a 65-year-old male with choroidal metastases (CM) from non-small cell lung cancer (NSCLC). Pembrolizumab (Keytruda) combined with pemetrexed and capecitabine achieved excellent outcomes. After two cycles of pembrolizumab and chemotherapy, blurred vision and left eye pain were significan...

Full description

Bibliographic Details
Main Authors: Xinsheng Li, Ya Liang, Jingfan Wang, Zizhong Hu, Zhi-Lan Yuan, Ping Xie
Format: Article
Language:English
Published: Taylor & Francis Group 2021-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
immunotherapy
choroidal metastases
non-small cell lung cancer
pembrolizumab
Online Access:http://dx.doi.org/10.1080/21645515.2021.1885282

Internet

http://dx.doi.org/10.1080/21645515.2021.1885282

Similar Items